Holen Sie sich die Stockscreener-App
23.39
0.21%
0.05
Handel nachbörslich:
23.51
0.12
+0.51%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$23.34
Offen:
$23.13
24-Stunden-Volumen:
2.15M
Relative Volume:
0.90
Marktkapitalisierung:
$4.74B
Einnahmen:
$3.94B
Nettoeinkommen (Verlust:
$-95.00M
KGV:
-23.16
EPS:
-1.01
Netto-Cashflow:
$279.00M
1W Leistung:
+0.69%
1M Leistung:
-7.26%
6M Leistung:
-17.32%
1J Leistung:
-19.92%
1-Tages-Spanne:
$22.84
$23.46
1-Wochen-Bereich:
$22.84
$23.84
52-Wochen-Spanne:
$22.84
$37.60
Dentsply Sirona Inc Stock (XRAY) Company Profile
Firmenname
Dentsply Sirona Inc
Sektor
Telefon
844-546-3722
Adresse
13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE, NC
Dentsply Sirona Inc Stock (XRAY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-16 | Eingeleitet | Needham | Buy |
| 2023-11-10 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-01-12 | Hochstufung | William Blair | Underperform → Mkt Perform |
| 2022-08-05 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2022-06-02 | Hochstufung | UBS | Neutral → Buy |
| 2022-04-20 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-04-20 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-04-19 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-04-19 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-08-06 | Bestätigt | Barrington Research | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-02 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2021-03-02 | Bestätigt | H.C. Wainwright | Neutral |
| 2021-01-05 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-12-18 | Herabstufung | Stifel | Buy → Hold |
| 2020-11-17 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-11-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-10-22 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-08-10 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-06-16 | Eingeleitet | Piper Sandler | Overweight |
| 2020-06-15 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-05-27 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2020-05-11 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-24 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-04-08 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-04-07 | Herabstufung | Goldman | Buy → Neutral |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-03-03 | Bestätigt | H.C. Wainwright | Neutral |
| 2020-02-19 | Bestätigt | Stifel | Buy |
| 2019-12-11 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2019-08-02 | Hochstufung | Wellington Shields | Hold → Gradually Accumulate |
| 2019-07-26 | Eingeleitet | Evercore ISI | In-line |
| 2019-07-09 | Bestätigt | H.C. Wainwright | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
Alle ansehen
Dentsply Sirona Inc Aktie (XRAY) Neueste Nachrichten
DENTSPLY SIRONA (NASDAQ:XRAY) Sets New 52-Week LowTime to Sell? - MarketBeat
An interview with Dr Melonie MacDonald on Primescan 2 - Dental Tribune US
Should You Buy, Sell or Hold DENTSPLY SIRONA Before Q3 Earnings? - Yahoo Finance
Tooth Regeneration Market Poised for Substantial Growth (2024-2031) | Dentsply Sirona, Datum Dental, Unilever. - openPR
Vanguard Group Inc's Strategic Reduction in Dentsply Sirona Inc Holdings - GuruFocus.com
Dentsply Sirona Inc. stock underperforms Monday when compared to competitors - MarketWatch
Endodontics Devices Market Analysis and Forecast 2024-2031: - openPR
Bronstein, Gewirtz & Grossman, LLC Is Investigating DENTSPLY SIRONA Inc. (XRAY) And Encourages Stockholders to Connect - AccessWire
VELA Investment Management LLC Takes $2.17 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
Dentsply Sirona Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
DENTSPLY SIRONA Inc. (XRAY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - AccessWire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against DENTSPLY SIRONA Inc. (XRAY) and Encourages Stockholders to Learn More About the Investigation - AccessWire
Dentsply Sirona Inc. stock outperforms competitors despite losses on the day - MarketWatch
DENTSPLY SIRONA (XRAY) Set to Announce Quarterly Earnings on Thursday - MarketBeat
Dentsply Sirona Inc. stock outperforms competitors on strong trading day - MarketWatch
Dentsply Sirona Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Europe Dental Implants Market Growth in Future Scope 2025-2030 | - openPR
Acrylic Teeth Market To Receive Overwhelming Hike In Revenue - openPR
Dentsply Sirona Shares Fall After Suspension of Byte Aligner Products - MSN
DENTSPLY SIRONA (NASDAQ:XRAY) Upgraded at StockNews.com - MarketBeat
Insider Stock Buying Reaches US$1.21m On DENTSPLY SIRONA - Simply Wall St
Short Interest in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Decreases By 14.8% - MarketBeat
Dental Bonding Agents Market Overall Study Report 2024-2032 | - openPR
Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Price Target at $32.67 - MarketBeat
Leerink maintains outperform rating on DENTSPLY stock despite Byte suspension - Investing.com Canada
Country Club Bank Invests $4.08 Million in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) - MarketBeat
Dentsply Sirona Inc. stock underperforms Friday when compared to competitors - MarketWatch
Dentsply stock hits 52-week low at $23.53 amid market challenges - Investing.com Australia
Dentsply Sirona voluntarily suspends sales of its Byte teeth aligners - Reuters
Needham & Company LLC Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $29.00 - MarketBeat
DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 52-Week Low Following Analyst Downgrade - MarketBeat
Restorative Dentistry Market Is Booming Worldwide | Envista, Dentsply Sirona, Ivoclar Vivadent - openPR
Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products - GlobeNewswire
Dentsply Sirona suspends sales of its Byte Aligners, Impression Kits voluntarily - Oral Health
Dentsply Sirona suspends sales and marketing for Byte aligners - Mass Device
U.S. Zirconia Based Dental Materials Market | Report, 2030 - Grand View Research
US Dental Implants Market Size by Key Players: 3M, Bicon, BioHorizons, Dentium Co. Ltd., DENTSPLY Sirona - openPR
Dentsply Sirona suspends sale of its Byte Aligners and Impression Kits - MSN
DENTSPLY SIRONA (NASDAQ:XRAY) Issues Q3 Earnings Guidance - MarketBeat
Dentsply Sirona Suspends Sales of Byte Aligners, Impression Kits - Morningstar
Dentsply Sirona Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Dentsply Sirona Provides Update on Byte Aligner Products - GlobeNewswire
Leading Abutment Implant Manufacturers in the USA: A Comprehensive Guide - Spherical Insights
SDR: 15 Years of Excellent Bulk Fill Technology - Dentistry Today
Analysts Offer Predictions for DENTSPLY SIRONA Q3 Earnings - MarketBeat
Dental Implants Market 2024-2031 Market Size Forecast: Growth - openPR
Endodontic Electric Motor System Market Industry Size - openPR
Implantable Medical Devices Market Future Business - openPR
Finanzdaten der Dentsply Sirona Inc-Aktie (XRAY)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dentsply Sirona Inc-Aktie (XRAY) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| LUCIER GREGORY T | Director |
May 31 '24 |
Buy |
27.95 |
3,577 |
99,976 |
58,374 |
| LUCIER GREGORY T | Director |
Nov 22 '23 |
Buy |
31.44 |
10,000 |
314,400 |
43,121 |
| Coleman Glenn | Executive VP & CFO |
Nov 20 '23 |
Buy |
29.70 |
10,000 |
297,000 |
73,566 |
| Campion Simon D | President, CEO & Member of BOD |
Nov 20 '23 |
Buy |
29.70 |
10,000 |
297,000 |
243,930 |
0.98%
5.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):